Product image of Norditropin Nordiflex (Somatropin) supplied by GNH India

Norditropin Nordiflex

Active Ingredient:
Somatropin
Origin:
EU

Norditropin Nordiflex (Somatropin)

Somatropin, the active ingredient in Norditropin Nordiflex, is a Human growth hormone presented as a solution for injection (pen injector) for subcutaneous use. It treats growth hormone deficiency in children and adults, Turner syndrome, Prader‑Willi syndrome, chronic renal insufficiency, and short stature due to idiopathic causes.

GNH India supplies Norditropin Nordiflex as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable cold‑chain logistics for biologic products globally.

Manufacturer / TM Owner

Novo Nordisk Pharma Sa

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Norditropin Nordiflex (somatropin) is used in growth hormone therapy to address conditions associated with growth hormone deficiency.

  • Growth hormone deficiency in children: promotes linear growth and improves height velocity.
  • Growth hormone deficiency in adults: enhances body composition, bone density, and quality of life.
  • Turner syndrome: supports growth and development in affected females.
  • Prader‑Willi syndrome: aids increase in stature and favorable changes in body composition.
  • Chronic renal insufficiency: facilitates growth in pediatric patients with renal disease.
  • Idiopathic short stature: helps achieve greater final adult height.

How It Works

  • Somatropin binds to growth hormone receptors on target cells, activating the JAK2‑STAT5 signaling pathway, which stimulates hepatic synthesis of insulin‑like growth factor‑1 (IGF‑1). Elevated IGF‑1 mediates anabolic effects, promoting protein synthesis, linear bone growth, lipolysis, and metabolic regulation, thereby supporting overall growth and tissue repair. The increased IGF‑1 also influences cartilage proliferation at the epiphyseal plates, and modulates glucose and lipid metabolism, contributing to the therapeutic outcomes observed in patients with deficiency.

Side Effects

Somatropin may be associated with a range of adverse reactions, varying from mild to serious.

Common Side Effects

  • Injection site reactions: pain, redness, or swelling at the injection site.
  • Headache: mild to moderate intensity.
  • Joint pain or stiffness: especially in the hips, knees, or shoulders.
  • Edema: peripheral swelling, often in the extremities.

Serious or Rare Side Effects

  • Intracranial hypertension: severe headache, visual disturbances, or papilledema.
  • Slipped epiphysis: premature closure or fracture of growth plates.
  • Severe allergic reaction: anaphylaxis, rash, or angioedema.

Precautions & Warnings

When prescribing somatropin, clinicians should consider several precautionary measures to ensure safe use.

  • Monitor glucose levels: patients with diabetes may experience hyperglycemia.
  • Assess for intracranial hypertension: watch for persistent headaches or visual changes.
  • Screen for malignancy: use with caution in individuals with active cancer.
  • Adjust dose in renal impairment: monitor growth response and IGF‑1 levels.
  • Avoid use during pregnancy unless benefits outweigh risks: limited safety data are available.
  • Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Avoid Interactions

Somatropin can interact with other medicines, affecting its efficacy or safety.

Major Interactions (Avoid)

  • Glucocorticoids: reduce the anabolic effect of somatropin and may blunt growth response.
  • Insulin or oral hypoglycemics: somatropin can alter glucose metabolism, requiring dose adjustments to avoid severe hyperglycemia or hypoglycemia.
  • Antidiabetic agents: may need close monitoring of blood sugar.

Moderate Interactions (Monitor Closely)

  • Oral estrogen therapy: can increase IGF‑1 levels, potentially enhancing effects of somatropin.
  • Thyroid hormone replacement: somatropin may affect thyroid function tests; monitor thyroid status.
  • Other growth hormone antagonists: concurrent use may diminish therapeutic benefit.

Frequently Asked Questions

Norditropin Nordiflex is a somatropin‑based growth hormone indicated for patients with growth hormone deficiency, Turner syndrome, Prader‑Willi syndrome, chronic renal insufficiency‑related growth failure, and idiopathic short stature. It helps stimulate linear growth in children and supports metabolic and body‑composition benefits in adults.

Somatropin binds to growth hormone receptors on cell surfaces, activating the JAK2‑STAT5 cascade. This triggers the liver to produce insulin‑like growth factor‑1 (IGF‑1), which drives protein synthesis, bone growth, lipolysis, and overall anabolic activity, thereby correcting the deficits caused by growth hormone deficiency.

The dose is individualized by the prescribing clinician based on factors such as patient age, weight, severity of deficiency, IGF‑1 levels, and treatment goals. Dosage adjustments are made during follow‑up to achieve optimal growth response while minimizing adverse effects.

Safety data for somatropin in pregnancy and lactation are limited. It is generally avoided unless the potential benefit justifies the potential risk to the fetus or infant. Women of child‑bearing potential should discuss contraception and treatment plans with their healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, cold‑chain shipping details, and necessary import documentation.

Norditropin Nordiflex delivers somatropin via a pre‑filled pen injector, offering precise dosing and ease of use compared with vial‑and‑syringe systems. Clinical efficacy is comparable to other recombinant human GH products, while the pen device may improve patient adherence and comfort.

The product must be stored refrigerated at 2‑8 °C (36‑46 °F). Keep it in the original packaging, protect it from light, and avoid freezing or shaking the pen. Once in use, follow the manufacturer’s guidance on the remaining shelf‑life at room temperature.

Norditropin Nordiflex is given as a subcutaneous injection using the dedicated pen injector. The injection site should be rotated among the abdomen, thigh, or upper arm to reduce local irritation. Patients or caregivers are trained on proper technique and dose setting.

Serious risks include intracranial hypertension (headache, visual changes), slipped epiphysis or growth‑plate fractures, abnormal glucose tolerance that may progress to diabetes, and potential tumor recurrence or progression in patients with a history of malignancy. Prompt medical evaluation is required if any of these occur.

Norditropin Nordiflex is contraindicated in individuals with known hypersensitivity to somatropin or any excipients, active malignancy, uncontrolled diabetes, or severe acute illness. Caution is also advised for patients with pre‑existing intracranial hypertension or active proliferative disorders.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Somatropin

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT